Provention Bio Key Fundamental Indicators
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Provention Bio, as well as the relationship between them.
Provention Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Provention Bio's valuation are provided below:Provention Bio does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Provention |
Search Suggestions
| PR | Permian Resources | Company |
| PRIF-PG | Priorityome Fund | Company |
| PRAPX | Pimco Total Return | Mutual Fund |
| PRB | Van Eck | ETF |
| PRA | PRA | Cryptocurrency |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Provention Bio has a Return On Equity of -0.9766. This is 95.93% lower than that of the Pharmaceuticals sector and 97.32% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Provention Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Provention Bio's current stock value. Our valuation model uses many indicators to compare Provention Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Provention Bio competition to find correlations between indicators driving Provention Bio's intrinsic value. More Info.Provention Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Provention Bio's earnings, one of the primary drivers of an investment's value.Provention Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Provention Bio's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Provention Bio could also be used in its relative valuation, which is a method of valuing Provention Bio by comparing valuation metrics of similar companies.Provention Bio is currently under evaluation in return on equity category among its peers.
Provention Fundamentals
| Return On Equity | -0.98 | |||
| Return On Asset | -0.43 | |||
| Operating Margin | (9.94) % | |||
| Current Valuation | 607.28 M | |||
| Shares Outstanding | 91.1 M | |||
| Shares Owned By Insiders | 4.61 % | |||
| Shares Owned By Institutions | 53.20 % | |||
| Number Of Shares Shorted | 5.37 M | |||
| Price To Book | 5.31 X | |||
| Price To Sales | 289.70 X | |||
| Revenue | 12.89 M | |||
| Gross Profit | (63.42 M) | |||
| EBITDA | (98.72 M) | |||
| Net Income | (113.56 M) | |||
| Cash And Equivalents | 84.52 M | |||
| Cash Per Share | 1.04 X | |||
| Total Debt | 23.47 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 3.59 X | |||
| Book Value Per Share | 1.39 X | |||
| Cash Flow From Operations | (75.41 M) | |||
| Short Ratio | 1.53 X | |||
| Earnings Per Share | (1.52) X | |||
| Target Price | 23.8 | |||
| Number Of Employees | 174 | |||
| Beta | 2.46 | |||
| Market Capitalization | 2.38 B | |||
| Total Asset | 236.86 M | |||
| Z Score | 60.6 | |||
| Net Asset | 236.86 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Provention Stock
If you are still planning to invest in Provention Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provention Bio's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |